-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: BIOTECH
World Health Day: The Global Impact of Vaccines
As we celebrate World Health Day today, it is an opportunity to remember that vaccines represent one of the most important global health investments. The investment of time, money and dedication has brought enormous benefits to the world. According to the World Health Organization, immunizations save an estimated 2.5 million lives every year from diphtheria, tetanus, pertussis (whooping cough), and measles. Biotechnology is helping us improve existing vaccines and create new vaccines against infectious agents. Read More >
Patent Reform Bill good for Biotech
Patent Reform Passes the Senate and Moves to the House Posted by Roy Zwahlen, manager of intellectual property and technology transfer policy at BIO. On March 8th, the Senate approved the America Invents Act (S. 23) by an overwhelming vote of 95-5. BIO supports this bipartisan, consensus-oriented bill, formerly known as the Patent Reform Act of 2011. Once enacted into law, it will strengthen and improve our nation’s patent system, spurring innovation and job creation. Patents are often Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: America Invents Act, best mode, BIO, BIOTECH, Biotechnology Industry, bipartisan, False marking, false patent marking, First inventor to file, First to file, first to invent, Grassley, Leahy, Patent and Trademark Office, Patent Reform, PTO, PTO Reexaminations, Senate Judiciary Comm, USPTO
Tags: America Invents Act, best mode, BIO, BIOTECH, Biotechnology Industry, bipartisan, False marking, false patent marking, First inventor to file, First to file, first to invent, Grassley, Leahy, Patent and Trademark Office, Patent Reform, PTO, PTO Reexaminations, Senate Judiciary Comm, USPTO
BIO’s Comments on proposed PTO Humanitarian Technologies and Licensing Through the Intellectual Property System
Here are the highlights from BIO’s recent submission on the proposed PTO “Request for Comments on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System.” Background: 1. “BIO’s members also understand that problems with access to medicines and other biotechnology products in the developing world have very little to do with the patent system, and are generally caused by other factors outside the control of individual stakeholders, such as lack of adequate local manufacturing, Read More >
Patently BIOtech
1 Comment
Email This Post
Tags: access to medicines, BIO, BIOTECH, biotechnology, Biotechnology Industry Organization, developing countries, economic development, Global Health, Green Technology, humanitarian, humanitarian technologies, International, Patent and Trademark Office, Patent Reform, patents, poverty, PTO, re-examination vouchers, U.S. Patent and Trademark Office, United States Patent and Trademark Office, USPTO
Tags: access to medicines, BIO, BIOTECH, biotechnology, Biotechnology Industry Organization, developing countries, economic development, Global Health, Green Technology, humanitarian, humanitarian technologies, International, Patent and Trademark Office, Patent Reform, patents, poverty, PTO, re-examination vouchers, U.S. Patent and Trademark Office, United States Patent and Trademark Office, USPTO
Jerry Pommer: Livestock Biotech Conference Preview
BIOtech Now visited with Jerry Pommer, Director of Animal Regulatory Compliance and Quality Assurance for Hematech, Inc. in Sioux Falls, South Dakota. Jerry is a member of the program steering committee for BIO’s first-ever Livestock Biotech Summit, which will provide participants with three days of cross-cutting discussions among industry, academic and government leaders on the care and use of animals in research and the many possibilities in the realm of GE animal research, regulation, and Read More >
The Livestock Biotech Summit is Coming!
Don’t miss your chance to get the special early-bird registration rate for the 2010 Livestock Biotech Summit. Registration is now open, and our early-bird discounts will expire on Thursday, July 29, 2010 at 11:59 pm Eastern Daylight Time. The first-ever Summit of its kind, scheduled for September 28-30, in Sioux Falls, S.D., will provide participants three days of cross-cutting discussions among industry, academic and government leaders. Program highlights include: -A unique workshop tailored specifically to Read More >
